KROS - Keros Therapeutics looks to raise $120M through public offering
2024-01-03 16:12:08 ET
More on Keros Therapeutics
- Keros Therapeutics: Interesting Early Data From A Promising Molecule (Downgrade)
- Keros falls after mid-stage data for blood cancer therapy
- Seeking Alpha’s Quant Rating on Keros Therapeutics
For further details see:
Keros Therapeutics looks to raise $120M through public offering